• 1

    Chen M, Daha MR, Kallenberg CG. The complement system in systemic autoimmune disease. J Autoimmun 2010; 34:J276J286.

  • 2

    Sethi S. Etiology-based diagnostic approach to proliferative glomerulonephritis. Am J Kidney Dis 2014; 63:561566.

  • 3

    Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis—a new look at an old entity. N Engl J Med 2012; 366:11191131.

  • 4

    Fakhouri F, et al.. C3 glomerulopathy: A new classification. Nat Rev Nephrol 2010; 6:494499.

  • 5

    Suzuki H, et al.. The pathophysiology of IgA nephropathy. J Am Soc Nephrol 2011; 22:17951803.

  • 6

    Maillard N, et al.. Current understanding of the role of complement in IgA nephropathy. J Am Soc Nephrol 2015; 26:15031512.

  • 7

    Espinosa M, et al.. Association of C4d deposition with clinical outcomes in IgA nephropathy. Clin J Am Soc Nephrol 2014; 9:897904.

  • 8

    Liu LL, et al.. Glomerular mannose-binding lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathy. Clin Exp Immunol 2013; 174:152160.

  • 9

    Liu L, et al.. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy. J Clin Immunol 2014; 34:224232.

  • 10

    Bomback AS. Anti-complement therapy for glomerular diseases. Adv Chronic Kidney Disease 2014; 21:152158.

Complement-Mediated Glomerular Diseases

Andrew Bomback Andrew Bomback, MD, MPH, is assistant professor of medicine in the division of nephrology at Columbia University Medical Center in New York, NY

Search for other papers by Andrew Bomback in
Current site
Google Scholar
PubMed
Close
Restricted access
Save